|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 901 New York Ave NW |
Address2 | Suite 515E |
City | Washington |
State | DC |
Zip Code | 20001-4432 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 1967-12
|
||||||||
|
6. House ID# 317210000
|
TYPE OF REPORT | 8. Year | 2023 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Lupe Gonzales Jr |
Date | 8/28/2023 12:56:20 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ALC
16. Specific lobbying issues
Opioids, pain management
Federal funding for Substance Use Disorder treatments
Reauthorization of Preventing Overdoses While in Emergency Rooms (POWER) program
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Senior Director, Grassroots Advocacy & Political Affairs |
|
Fred |
Essis |
|
Congressional Lobbyist |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Federal funding to implement Preventing Overdoses While in Emergency Rooms (POWER) program
Federal funding to implement MISSION ZERO program
Federal funding to for firearm safety and injury prevention research
Federal funding to implement Emergency Medical Services for Children (EMSC)
Federal funding for emergency medicine research activities
Federal funding for implementation of Dr. Lorna Breen Health Care Provider Protection Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Senior Director, Grassroots Advocacy & Political Affairs |
|
Fred |
Essis |
|
Congressional Lobbyist |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DIS
16. Specific lobbying issues
Access to emergency medical supplies (including Personal Protective Equipment, COVID-19 tests, ventilators, and medications) during COVID-19 public health emergency
Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA)
H.R. 4420, the Preparedness and Response Reauthorization Act
H.R. 4421, the Preparing for All Hazards and Pathogens Reauthorization Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Senior Director, Grassroots Advocacy and Political Affairs
|
|
Fred |
Essis |
|
Congressional Lobbyist |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
H.R.1202-REDI Act, to amend the Higher Education Act of 1965 to provide for interest-free deferment on student loans for borrowers serving in a medical or dental internship or residency program.
S.704-REDI Act, to amend the Higher Education Act of 1965 to provide for interest-free deferment on student loans for borrowers serving in a medical or dental internship or residency program
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Senior Director, Grassroots Advocacy & Political Advocacy |
|
Fred |
Essis |
|
Congressional Lobbyist |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FIR
16. Specific lobbying issues
Federal funding for firearms safety and injury prevention research
Firearms safety and injury prevention policy
H.R. 715-Bipartisan Background Checks Act of 2023
S. 494-Background Check Expansion Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Senior Director, Grassroots Advocacy & Political Affairs |
|
Fred |
Essis |
|
Congressional Lobbyist |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Reproductive health, physician-patient relationship, and EMTALA issues
Emergency department boarding
Drug shortages
Health care consolidation
H.R.1694-Emergency Care Improvement Act, to permanently allow for coverage under Medicare and Medicaid of services that are provided by freestanding emergency centers.
H.R. 2416-To reauthorize the MISSION ZERO military-civilian partnership for trauma readiness
H.R. 2940-PASTEUR Act of 2023, to incentivize new antimicrobial development
S. 1346-Improving Mental Health Access from the Emergency Department Act
S. 1355- PASTEUR Act of 2023, to incentivize new antimicrobial development
S. 1447-Bipartisan Solution to Cyclical Violence Act of 2023, to establish a grant program to support trauma center violence intervention and violence prevention programs
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Senior Director, Grassroots Advocacy & Political Affairs |
|
Fred |
Essis |
|
Congressional Lobbyist |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
No Surprises Act implementation
Eliminating prior authorization requirements in Medicare Advantage
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Senior Director, Grassroots Advocacy & Political Affairs |
|
Fred |
Essis |
|
Congressional Lobbyist |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
Workplace violence prevention for health care workers
H.R. 731-Workforce Mobility Act of 2023, to prohibit the use of noncompete agreements
H.R. 2584-Safety from Violence for Healthcare Employees (SAVE) Act, to establish
H.R. 2663-Workplace Violence Prevention for Health Care and Social Service Workers Act, to require OSHA to issue workplace violence prevention standards to protect health care and social service workers
S. 220-Workforce Mobility Act of 2023, to prohibit the use of noncompete agreements
S. 1176-Workplace Violence Prevention for Health Care and Social Service Workers Act, to require OSHA to issue workplace violence prevention standards to protect health care and social service workers
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Senior Director, Grassroots Advocacy & Political Affairs |
|
Fred |
Essis |
|
Congressional Lobbyist |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Federal funding for emergency medicine research activities
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Senior Director, Grassroots Advocacy & Political Affairs |
|
Fred |
Essis |
|
Congressional Lobbyist |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Physician payment reform
Counting observation stays as satisfying Medicare three-day inpatient stay prerequisite for skilled nursing facility (SNF) coverage
H.R. 2474-Strengthening Medicare for Patients and Providers Act, to add an inflationary adjustment to physician payments under the Medicare Physician Fee Schedule
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Senior Director, Grassroots Advocacy & Political Affairs |
|
Fred |
Essis |
|
Congressional Lobbyist |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LAW
16. Specific lobbying issues
Fentanyl analogues scheduling extension
S.1080-Cooper Davis Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Senior Director, Grassroots Advocacy & Political Affairs |
|
Fred |
Essis |
|
Congressional Lobbyist |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AVI
16. Specific lobbying issues
Updating first aid and emergency medical kits and flight crew training requirements
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Senior Director, Grassroots Advocacy and Political Affairs |
|
Fred |
Essis |
|
Congressional Lobbyist |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |